Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment

Clicks: 226
ID: 270398
2017
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment
Reference Key
p2017journaleffects Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rafouli-Stergiou P;Parissis JT;Farmakis D;Bistola V;Frogoudaki A;Vasiliadis K;Ikonomidis I;Paraskevaidis I;Kremastinos D;Filippatos G;Lekakis J;;
Journal Journal of cardiovascular medicine (Hagerstown, Md.)
Year 2017
DOI DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/25643197
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine female male observational study kidney / drug effects* biomarkers / blood heart failure / complications heart failure / drug therapy* simendan hydrazones / therapeutic use* pyridazines / therapeutic use* john t parissis cardiotonic agents / therapeutic use* pmid:25643197 doi:10.2459/jcm.0000000000000244 pinelopi rafouli-stergiou john lekakis cardiotonic agents / pharmacology cystatin c / blood* hydrazones / pharmacology pyridazines / pharmacology renal insufficiency / blood renal insufficiency / complications*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.